Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease

Previous work demonstrated that progesterone (PROG) treatment attenuates morphological, molecular and functional abnormalities in the spinal cord of the Wobbler (Wr) mouse, a genetic model of motoneuron degeneration. Wr mice show a marked up-regulation of the nitric oxide synthesizing enzyme (NOS)....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: González Deniselle, M.C
Otros Autores: Garay, L., López-Costa, J.J, González, S., Mougel, A., Guennoun, R., Schumacher, M., De Nicola, A.F
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2004
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 15191caa a22015257a 4500
001 PAPER-21207
003 AR-BaUEN
005 20230518205238.0
008 190411s2004 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-2942701786 
024 7 |2 cas  |a 3alpha hydroxy 5alpha pregnan 20 one, 516-54-1; 5alpha pregnane 3,20 dione, 566-65-4; methylprednisolone, 6923-42-8, 83-43-2; nitric oxide synthase, 125978-95-2; progesterone, 57-83-0; reduced nicotinamide adenine dinucleotide phosphate dehydrogenase, 9001-68-7; NADPH Dehydrogenase, EC 1.6.99.1; Nitric Oxide Synthase, EC 1.14.13.39; Progesterone, 57-83-0 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a BRREA 
100 1 |a González Deniselle, M.C. 
245 1 0 |a Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease 
260 |c 2004 
270 1 0 |m De Nicola, A.F.; Lab. of Neuroendocrine Biochemistry, Inst. de Biol. Y Med. Experimental, University of Buenos Aires, Obligado 2490, 1428 Buenos Aires, Argentina; email: denicola@dna.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Abe, K., Morita, S., Kikuchi, T., Itoyama, Y., Protective effect of a novel free-radical scavenger, OPC-14117, on Wobbler mouse motor neuron disease (1997) J. Neurosci. Res., 48, pp. 63-70 
504 |a Azcoitia, I., Leonelli, E., Magnaghi, V., Veiga, S., Garcia-Segura, L.M., Melcangi, R.C., Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats (2003) Neurobiol. Aging, 24, pp. 853-860 
504 |a Beal, M.F., Mitochondrial dysfunction in neurodegenerative diseases (1998) Biochem. Biophys. Acta, 1366, pp. 217-233 
504 |a Boillée, S., Peschanski, M., Junier, M.-P., The Wobbler mouse: A neurodegeneration jigsaw puzzle (2003) Mol. Neurobiol., 28, pp. 65-106 
504 |a Clarke, P.G.H., Developmental cell death: Morphological diversity and multiple mechanisms (1990) Anat. Embryol., 181, pp. 195-213 
504 |a Clowry, G.J., McHanwell, S., Expression of nitric oxide synthase by motor neurons in the spinal cord of the mutant mouse Wobbler (1996) Neurosci. Lett., 215, pp. 177-180 
504 |a Corvino, V., Businaro, R., Geloso, M.C., Bigini, P., Caballo, V., Pompili, E., Mennini, T., Michetti, F., S100B protein and 4-hydroxynonenal in the spinal cord of Wobbler mice (2003) Neurochem. Res., 28, pp. 341-345 
504 |a Dave, K.R., Bradley, W.G., Pérez Pinzón, M.A., Early mitochondrial dysfunction occurs in motor cortex and spinal cord at the onset of disease in the Wobbler mouse (2003) Exp. Neurol., 182, pp. 412-420 
504 |a Desarnaud, F., Do Thi, A.M., Brown, G., Lemke, G., Suter, U., Baulieu, E.E., Schumacher, M., Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells (1998) J. Neurochem., 71, pp. 1765-1768 
504 |a González Deniselle, M.C., Grillo, C., González, S., Roig, P., De Nicola, A.F., Evidence for down-regulation of GAP-43 mRNA in Wobbler mouse spinal motoneurons by corticosterone and a 21-aminosteroid (1999) Brain Res., 841, pp. 78-84 
504 |a González Deniselle, M.C., González, S., Lima, A., Wilkin, G., De Nicola, A.F., The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPHDiaphorase in the spinal cord of Wobbler mouse, a model for Amyotrophic Lateral Sclerosis (1999) Neurochem. Res., 24, pp. 1-8 
504 |a González Deniselle, M.C., González, S., De Nicola, A.F., Cellular basis of steroid neuroprotection in the Wobbler mouse, a model for motoneuron disease (2001) Cell. Mol. Neurobiol., 21, pp. 237-254 
504 |a González Deniselle, M.C., López Costa, J.J., Pecci Saavedra, J., Pietranera, L., González, S., Garay, L., Guennoun, R., De Nicola, A.F., Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease (2002) Neurobiol. Dis., 11, pp. 457-468 
504 |a González Deniselle, M.C., López Costa, J.J., González, S., Labombarda, F., Garay, L., Guennoun, R., Schumacher, M., De Nicola, A.F., Basis of progesterone protection in spinal cord neurodegeneration (2003) J. Steroid Biochem. Mol. Biol., 83, pp. 199-209 
504 |a Guang-Ping, X., Dave, K.R., Moraes, C.T., Busto, R., Sick, T.J., Bradley, W.G., Pérez-Pinzón, M.A., Dysfunctional mitochondrial respiration in the Wobbler mouse brain (2001) Neurosci. Lett., 300, pp. 141-144 
504 |a Gurney, M.E., What transgenic mice tell us about neurodegenerative disease (2000) BioEssays, 22, pp. 297-304 
504 |a Hall, E.D., Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury (1993) Cell. Mol. Neurobiol., 13, pp. 415-432 
504 |a Hall, E.D., Braughler, J.M., Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and (Na, K)-ATPase activity. Dose response analysis during 1st hour after contusion injury in the cat (1982) J. Neurosurg., 49, pp. 563-568 
504 |a Henderson, J.T., Javaheri, M., Kopko, S., Roder, J.C., Reduction of lower motor neuron degeneration in wobbler mice by n-acetyl-L-cysteine (2000) J. Neurosci., 16, pp. 7574-7582 
504 |a Ikeda, K., Iwasaki, Y., Kinoshita, M., Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the Wobbler mouse (1988) J. Neurol. Sci., 160, pp. 9-15 
504 |a Koenig, H.L., Schumacher, M., Ferzaz, B., Do Thi, A.N., Ressouches, A., Guennoun, R., Jung-Testas, I., Baulieu, E.E., Progesterone synthesis and myelin formation by Schwann cells (1995) Science, 268, pp. 1500-1502 
504 |a Kong, J., Zu, Z., Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1 (1998) J. Neurosci., 18, pp. 3241-3250 
504 |a Labombarda, F., González, S., Roig, P., Lima, A., Guennoun, R., Schumacher, M., De Nicola, A.F., Modulation of NADPHDiaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured spinal cord (2000) J. Steroid Biochem. Mol. Biol., 73, pp. 159-169 
504 |a Labombarda, F., González, S., González Deniselle, M.C., Guennoun, R., Schumacher, M., De Nicola, A.F., Cellular basis for progesterone neuroprotection in the injured spinal cord (2002) J. Neurotrauma, 19, pp. 343-355 
504 |a Labombarda, F., González, S., González Deniselle, M.C., Vinson, G.P., Schumacher, M., De Nicola, A.F., Guennoun, R., Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25 Dx in the rat spinal cord (2003) J. Neurochem., 87, pp. 902-913 
504 |a Lehmann, A., (1974) Atlas Stereotaxique du Cerveau de la Souris, , Paris: Editions du Centre National de la Recherche Scientifique 
504 |a Melcangi, R.C., Magnaghi, V., Martini, L., Aging in peripheral nerves: Regulation of myelin protein genes by steroid hormones (2000) Prog. Neurobiol., 60, pp. 291-308 
504 |a Mitsumoto, H., Bradley, W.G., Murine motor neuron disease (the Wobbler mouse): Degeneration and regeneration of the lower motor neuron (1982) Brain Res., 105, pp. 811-834 
504 |a Phul, R.K., Shaw, P.J., Ince, P.G., Smith, M.E., Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis (2000) Amyotroph. Lateral Scler. Other Mot. Neuron Disord., 4, pp. 259-267 
504 |a Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A., Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide (1991) Arch. Biochem. Biophys., 288, pp. 481-487 
504 |a Roof, R., Hall, E.D., Gender differences in acute CNS trauma and stroke: Neuroprotective effects and progesterone (2000) J. Neurotrauma, 17, pp. 367-388 
504 |a Roof, R., Duvdevani, R., Braswell, L., Stein, D.G., Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats (1994) Exp. Neurol., 129, pp. 64-69 
504 |a Roof, R., Hoffman, S., Stein, D.G., Progesterone protects against lipid peroxidation following traumatic brain injury in rats (1997) Mol. Chem. Neuropathol., 31, pp. 1-11 
504 |a Rupprecht, R., Reul, J.M., Trapp, T., Van Steensel, B., Wetzel, C., Damm, K., Zieglgansberger, W., Holsboer, F., Progesterone receptor-mediated effects of neuroactive steroids (1993) Neuron, 11, pp. 523-530 
504 |a Saravia, F., González, S., Roig, P., Alves, V., Homo-Delarche, F., De Nicola, A.F., Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse (2001) Cell. Mol. Neurobiol., 21, pp. 15-27 
504 |a Sasaki, S., Warita, H., Abe, K., Iwata, M., Neuronal nitric oxide synthase (nNos) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene (2002) Acta Neuropathol., 103, pp. 421-427 
504 |a Schumacher, M., Akwa, I., Guennoun, R., Robert, F., Labombarda, F., Desarnaud, F., Robel, P., Baulieu, E.E., Steroid synthesis and metabolism in the nervous system: Trophic and protective effects (2000) J. Neurocytol., 29, pp. 307-326 
504 |a Stein, D.G., Fulop, Z.L., Progesterone and recovery after traumatic brain injury: An overview (1998) Neuroscientist, 4, pp. 435-442 
504 |a Stewart, V.C., Heslegrave, A.J., Brown, G.C., Clark, J.B., Heales, J.R., Nitric-oxide dependent damage to neuronal mitochondria involves the NMDA receptor (2002) Eur. J. Neurosci., 15, pp. 458-464 
504 |a Thomas, A., Nockels, R., Pan, H., Shaffrey, C., Chopp, M., Progesterone is neuroprotective after acute experimental spinal cord trauma in rats (1999) Spine, 24, pp. 2134-2138 
504 |a Tsuzaka, K., Ishiyama, T., Pioro, E.P., Mitsumoto, H., Role of brain-derived neurotrophic factor in Wobbler mouse motor neuron disease (2001) Muscle Nerve, 24, pp. 474-480 
504 |a Vincent, S.R., Kimura, H., Histochemical mapping of nitric oxide synthase in the rat brain (1992) Neuroscience, 46, pp. 755-784 
504 |a Yung, K.K.L., Tang, F., Vacca-Galloway, L.L., Changes of neuropeptides in spinal cord and brain stem of Wobbler mouse at different stages of motoneuron disease (1992) Neuroscience, 50, pp. 209-222 
520 3 |a Previous work demonstrated that progesterone (PROG) treatment attenuates morphological, molecular and functional abnormalities in the spinal cord of the Wobbler (Wr) mouse, a genetic model of motoneuron degeneration. Wr mice show a marked up-regulation of the nitric oxide synthesizing enzyme (NOS). Since nitric oxide is a highly reactive species, it may play a role in neuropathology of Wr mice. We now studied if PROG neuroprotection involved changes of NOS activity in motoneurons and astrocytes, determined by the nicotinamide adenine dinucleotide phosphate-diaphorase (NADPHD) histochemical reaction. Two and four-month-old Wr mice at the progressive and stabilization stages of the disease, respectively, and their age-matched controls were left untreated or received a single 20-mg PROG pellet for 18 days. PROG reduced the high number of NADPHD-active motoneurons and white matter astrocytes in 2-month-old Wr mice but was unable to change the low number of NADPHD-active motoneurons in 4-month-old Wr mice or astrocytes in this age group. A large number of motoneurons in 2-month-old Wr mice showed a vacuolated phenotype, which was significantly reverted by PROG treatment. In summary, PROG treatment during the early symptomatic stage of the disease caused a significant reduction of NADPHD-active motoneurons and astrocytes and also reduced vacuolated degenerating cells, suggesting that blockade of NO synthesis and oxidative damage may contribute to steroid neuroprotection. © 2004 Elsevier B.V. All rights reserved.  |l eng 
593 |a Lab. of Neuroendocrine Biochemistry, Inst. de Biol. Y Med. Experimental, University of Buenos Aires, Obligado 2490, 1428 Buenos Aires, Argentina 
593 |a Department of Human Biochemistry, Faculty of Medicine, University of Buenos Aires, Obligado 2490, 1428 Buenos Aires, Argentina 
593 |a Inst. Biol. Cel. Y Neurociencias P., Facultad de Medicina, University of Buenos Aires, Argentina 
593 |a Inst. Univ. de Ciencias de la Salud, Fundación Barceló, Buenos Aires, Argentina 
593 |a INSERM U488, Hôpital de Bicêtre, Paris, France 
690 1 0 |a ENDOCRINE AND AUTONOMIC REGULATION 
690 1 0 |a MOTONEURON DISEASE 
690 1 0 |a NEUROENDOCRINE REGULATION: OTHER 
690 1 0 |a NEUROPROTECTION 
690 1 0 |a NITRIC OXIDE SYNTHASE 
690 1 0 |a PROGESTERONE 
690 1 0 |a WOBBLER MOUSE 
690 1 0 |a 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE 
690 1 0 |a 5ALPHA PREGNANE 3,20 DIONE 
690 1 0 |a METHYLPREDNISOLONE 
690 1 0 |a NITRIC OXIDE SYNTHASE 
690 1 0 |a PROGESTERONE 
690 1 0 |a REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a ASTROCYTE 
690 1 0 |a CELL VACUOLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DISEASE COURSE 
690 1 0 |a DRUG BLOOD LEVEL 
690 1 0 |a DRUG EFFECT 
690 1 0 |a DRUG POTENCY 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a FEMALE 
690 1 0 |a HISTOCHEMISTRY 
690 1 0 |a MALE 
690 1 0 |a MOTONEURON 
690 1 0 |a MOTOR NEURON DISEASE 
690 1 0 |a MOUSE 
690 1 0 |a NEUROPROTECTION 
690 1 0 |a NONHUMAN 
690 1 0 |a PHENOTYPE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a WHITE MATTER 
690 1 0 |a ANIMALS 
690 1 0 |a ASTROCYTES 
690 1 0 |a CELL COUNT 
690 1 0 |a DOWN-REGULATION 
690 1 0 |a FEMALE 
690 1 0 |a MALE 
690 1 0 |a MICE 
690 1 0 |a MICE, NEUROLOGIC MUTANTS 
690 1 0 |a MOTOR NEURON DISEASE 
690 1 0 |a MOTOR NEURONS 
690 1 0 |a NADPH DEHYDROGENASE 
690 1 0 |a NITRIC OXIDE SYNTHASE 
690 1 0 |a PROGESTERONE 
700 1 |a Garay, L. 
700 1 |a López-Costa, J.J. 
700 1 |a González, S. 
700 1 |a Mougel, A. 
700 1 |a Guennoun, R. 
700 1 |a Schumacher, M. 
700 1 |a De Nicola, A.F. 
773 0 |d 2004  |g v. 1014  |h pp. 71-79  |k n. 1-2  |p Brain Res.  |x 00068993  |w (AR-BaUEN)CENRE-4052  |t Brain Research 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942701786&doi=10.1016%2fj.brainres.2004.04.004&partnerID=40&md5=fe14828571f40b9c6f7ee875cfb798fc  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.brainres.2004.04.004  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00068993_v1014_n1-2_p71_GonzalezDeniselle  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00068993_v1014_n1-2_p71_GonzalezDeniselle  |y Registro en la Biblioteca Digital 
961 |a paper_00068993_v1014_n1-2_p71_GonzalezDeniselle  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 82160